Study: Aspirin cuts death risk in prostate cancer patients

10/25/2010 | WebMD

Preliminary results from a large study show that anti-coagulants, particularly aspirin, reduced the risk of death by more than 50% for men with prostate cancer that had not spread beyond the gland. Patients who took anti-coagulants were also less likely to experience cancer recurrence than those who didn't take such drugs.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ